Facing rising overdoses, VCU Health strengthens bridge between urgent ER care and long-term addiction services
Emergency departments across the United States experienced a surge in opioid overdose cases during the pandemic. Now, a program at VCU Health aims to help those patients receive the treatment they need after they leave the emergency department. The new VCU Health Virtual Bridge Clinic creates a direct link between the emergency department and treatment […]
Memorial lectureship on opioid crisis will honor VCU professor’s son
A new lecture series at Virginia Commonwealth University will address the opioid crisis, honoring the son of a VCU professor who died of an overdose. The Adam Abubaker Memorial Lecture will bring experts and leaders together annually to focus on topics related to addiction medicine. Lecturers will present on prevention, treatment, and community health in […]
Second Opportunities for Lasting Change
This story originally appeared in the MCV Foundation‘s Next magazine. To read the full story and other articles about life-changing innovations occurring on the MCV Campus, click here. Those who survive an opioid overdose usually do so because they’re found in varying states of consciousness by family members, friends, caregivers or first responders before their […]
Q&A with Wright Center researcher Brian A. Taylor, Ph.D.
By Emi Endo VCU College of Engineering A medical imaging physicist, Brian A. Taylor, Ph.D., is an assistant professor in the VCU Department of Biomedical Engineering and a researcher at the C. Kenneth and Dianne Wright Center for Clinical and Translational Research. 1. What are you working on right now? I’m working on innovative ways to […]
VCU to lead clinical trial assessing preventive treatment for patients recovering from opioid overdose
The Wright Center for Clinical and Translational Research will provide funding and research infrastructure for this opioid clinical trial. Dr. Moeller, the Center’s director, will serve as principal investigator on the trial! Monday, Dec. 4, 2017 Virginia Commonwealth University today announced that it is leading a clinical trial to test SUBLOCADE™ (buprenorphine extended-release) injection for subcutaneous use (CIII), […]